Business Context and Reporting Period
This Form 8-K is a current report filed by Keros Therapeutics, Inc. on September 2, 2021. The filing serves to disclose upcoming participation by the Company's President and Chief Executive Officer, Jasbir Seehra, in two major healthcare investment conferences.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of corporate events and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are reported in this document. The filing solely announces scheduled conference appearances.
Guidance, Outlook, and Management Commentary
- Conference Participation: CEO Jasbir Seehra is scheduled to speak at the following events:
- Morgan Stanley 19th Annual Global Healthcare Conference: Friday, September 10, 2021, at 11:00 am ET.
- H.C. Wainwright 23rd Annual Global Investment Conference: Monday, September 13, 2021, starting at 7:00 am ET.
- Legal Disclaimer: The information furnished in this report and the accompanying press release (Exhibit 99.1) is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details regarding the Company's pipeline or strategy discussed at the conferences.
- Confirm the Company's status as an emerging growth company (indicated as yes in the filing).
- Review subsequent filings (e.g., 10-Q or 10-K) for actual financial performance data, as this 8-K contains none.